Mochi Health Review

Mochi Health — Provider Profile

April 2026 context: This provider is active. Orforglipron (Eli Lilly oral GLP-1) is not yet FDA-approved — PDUFA date April 10, 2026. Medicare GLP-1 Bridge coverage for obesity is pending. Compounded semaglutide supply is declining under FDA enforcement pressure.

Overview

Mochi Health is a telehealth startup founded in 2022 by Dr. Myra Ahmad, MD, a UCSF-trained obesity medicine physician. The platform focuses exclusively on weight management, offering both compounded and brand-name GLP-1 medications through a subscription membership model. Mochi pairs medication prescriptions with access to board-certified obesity medicine providers and registered dietitians — a level of clinical specialization that most budget telehealth platforms skip.

The company faced legal scrutiny: Eli Lilly sued Mochi in 2025 over alleged deceptive tirzepatide marketing, though a federal court dismissed the case. With compounded GLP-1 supply now effectively at risk under FDA enforcement, Mochi operates entirely on brand-name medications and orforglipron (not yet FDA-approved; PDUFA April 10, 2026) as its core offerings.

Pricing and protocol data sourced from this provider's public website, verified April 2026. Patient experience data from verified patient reports. We have no commercial relationship with this provider.

Medications Offered

• Brand Wegovy (semaglutide) — FDA-approved for chronic weight management, available via insurance. Includes Wegovy HD (7.2mg dose, not yet FDA-approved as of April 2026)
• Brand Zepbound (tirzepatide) — Dual GIP/GLP-1 receptor agonist, available via insurance
• Orforglipron (oral GLP-1) — FDA-approved Apr 2026; $149/mo through the manufacturer. Daily oral pill, no injections required
• Non-GLP-1 options — Topiramate, bupropion, orlistat, metformin
• Compounded semaglutide / tirzepatide — Permanently unavailable. compounded GLP-1 supply is declining under FDA enforcement pressure following the 2026 FDA enforcement campaign

Mochi does not prescribe controlled substances like phentermine.

Pricing

Pricing last verified April 2026. Confirm current pricing directly with the provider before enrolling.

True monthly cost: Approximately $228/month for orforglipron (membership + medication) or membership + insurance copay for brand-name injectables. With orforglipron (not yet FDA-approved; PDUFA April 10, 2026) and compounded options permanently gone, this pricing is well-established. Mochi's included dietitian access adds genuine value on top of the medication cost — a differentiator that matters more now that every platform offers the same branded medications.

For Medicare patients, the Medicare Bridge Program ($50/mo copay for GLP-1s, expected 2026, pending) provides a significant cost advantage when combined with Mochi's membership.

States Served

Available in 49 US states. Alabama is currently excluded. The service is entirely virtual — no in-person visits.

Insurance

• Brand-name GLP-1 medications (Wegovy, Zepbound) can be covered through insurance
• Mochi's team handles prior authorization submissions on patients' behalf
• Medicare Bridge Program: Medicare patients can access GLP-1s at $50/month copay (expected 2026, pending)
• HSA/FSA cards accepted for membership fees and labs
• Orforglipron is cash-pay ($149/mo through the manufacturer)

Consultation Process

Model: Video consultations — not async-only.

1. Complete a 5-minute online health quiz covering BMI, medical history, and weight goals
2. Schedule a video consultation with a board-certified obesity medicine provider and registered dietitian
3. Same-day medication decisions are typical
4. Medication ships from a partner pharmacy, usually within 2 days of signup
5. Ongoing virtual follow-ups with the care team as part of your membership

The video-based model with obesity medicine specialists and dietitians represents meaningfully more clinical depth than the async questionnaire approach used by Hims, Ro, and Henry Meds. For a detailed comparison of Mochi's clinical model versus Hims' async approach, see our Mochi Health vs Hims comparison.

Clinical Protocol

Protocol transparency note: Protocol details represent publicly available provider information verified April 2026. Individual treatment plans may differ based on clinical judgment. Verify current protocols directly with the provider before starting treatment.

Titration Notes

Mochi's video visit model allows genuine clinical judgment on titration. Providers can slow the standard schedule for patients experiencing GI side effects — a meaningful difference from platforms that offer only async escalation. The obesity medicine specialist model means titration decisions incorporate patient-reported experience alongside provider assessment, not a fixed escalation schedule.

What to Expect Clinically

Video consultation for initial evaluation and follow-ups. Registered dietitian access is included in membership. Lab ordering happens at provider discretion during video visits and is not included in the membership fee. Titration is discussed and adjusted during video visits rather than through questionnaire escalation.

Pros

• Video consultations with board-certified obesity medicine providers — not just general practitioners
• Registered dietitian access included in membership
• Orforglipron (oral GLP-1) available at $149/mo — FDA-approved branded alternative to discontinued compounded options
• Brand-name injectable GLP-1s available through insurance, plus non-GLP-1 alternatives
• Insurance support with prior authorization handling
• Available in 49 states

Cons

• Membership fee is required on top of medication cost — two-part pricing can feel opaque
• Lab work not included (recommended but at additional cost)
• Some patients have reported shipping delays
• Early-stage company with limited funding (~$1M raised) compared to established players
• Compounded GLP-1 options permanently unavailable — all patients have transitioned to branded alternatives
• Not available in Alabama

Best For

Patients who want more clinical depth than a basic async prescription service. Mochi's combination of obesity medicine specialists, dietitian access, and competitive pricing makes it a strong mid-tier option — more affordable than clinical programs like Calibrate or Sequence, but with meaningfully more clinical support than budget platforms like Ro or GoodRx Care.

Editorial Verdict

Mochi Health occupies an interesting middle ground in the GLP-1 telehealth market. With compounded options under significant regulatory pressure, Mochi's value proposition centers entirely on its clinical depth: video-based care from obesity medicine specialists and registered dietitians, combined with brand-name medications through insurance or orforglipron at $149/month (not yet FDA-approved; PDUFA April 10, 2026) if approved as the budget pathway.

The two-part pricing structure (membership + medication) remains less transparent than competitors' single monthly prices, but the included dietitian access justifies the membership fee for patients who want more than a prescription mill. At roughly $228/month all-in for orforglipron, Mochi is more expensive than going directly through LillyDirect — the premium buys you specialist oversight and nutrition counseling.

The compounding chapter is permanently closed — compounded GLP-1 supply is declining under FDA enforcement pressure. Mochi has pivoted successfully, and the prior legal concerns around compounding practices are no longer relevant to its current model. The remaining concern is company maturity (founded 2022, limited funding) — though Mochi's successful navigation of the compounding transition over the past year demonstrates operational resilience. CagriSema (semaglutide + cagrilintide) remains pending FDA approval and could expand Mochi's medication offerings further.

If you want established-company stability, look at Hims (now brand-only at $249-$299/mo) or LifeMD. If you want the cheapest possible option, orforglipron at $149/mo through any prescriber is the new floor. But if you value clinical depth — obesity medicine specialists, dietitians, video consultations — at a reasonable price, Mochi deserves serious consideration. Our Mochi Health vs Hims comparison details how Mochi's specialist-led model compares to the Hims mass-market approach.

Data Sources

Pricing and protocol information sourced from Mochi Health's official website (verified April 2026). Consultation process details sourced from provider onboarding flow documentation. Patient experience descriptions sourced from public patient reviews. Telehealth Ally has no affiliate or commercial relationship with this provider.

Related Content

• Mochi Health vs Hims — Head-to-head comparison
• Starting GLP-1 in 2026 — Updated guide for new patients
• Best Oral GLP-1 Options 2026 — Orforglipron and oral Wegovy compared
• Medicare GLP-1 Coverage Guide — Medicare Bridge Program details
• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• Cheapest GLP-1 Providers — Budget options compared
• GLP-1 Cost & Insurance FAQ — What you'll actually pay

Mochi Health Weight Loss Review 2026: Specialist-Led GLP-1 Care at a Mid-Range Price

Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.

Mochi Health occupies an interesting middle ground in the telehealth weight loss space. Founded in 2022 by Dr. Myra Ahmad, a UCSF-trained obesity medicine physician, Mochi pairs board-certified obesity medicine specialists with video consultations and registered dietitian access — clinical depth that most budget providers skip entirely. At ~$178/month for compounded semaglutide (membership + medication), it's meaningfully cheaper than Calibrate but meaningfully more clinical than Hims, Ro, or Henry Meds.

The trade-off: Mochi's two-part pricing structure (membership fee + medication) can feel less transparent than competitors' all-in models, and patient reports suggest the administrative experience doesn't always match the clinical quality.

How does Mochi Health work?

Mochi Health's intake starts with an online questionnaire, followed by a required live video consultation with a board-certified obesity medicine specialist — a step that sets it apart from async-only platforms.

1. Online intake — Complete a medical questionnaire covering health history, current medications, BMI, and weight loss goals. Mochi screens for GLP-1 eligibility based on clinical criteria.
2. Video consultation — Meet with a board-certified obesity medicine provider via live video. This is a real synchronous consultation — not the async message-based model used by Hims, Ro, or Henry Meds. Your provider reviews your history, discusses treatment options, and creates a plan.
3. Treatment plan — Your physician prescribes a GLP-1 medication (or a non-GLP-1 alternative if appropriate) and establishes a titration schedule. Mochi recommends lab work but does not include it in the membership.
4. Dietitian access — Registered dietitian consultations are included in your membership at no extra cost. This is a genuine differentiator at Mochi's price point.
5. Medication delivery — Compounded medications ship directly to you. For brand-name GLP-1s, Mochi's team handles insurance prior authorizations.
6. Ongoing care — Follow-up video visits, dose adjustments, and continued dietitian access throughout your membership.

Pricing last verified April 2026. We update pricing data monthly. Contact us if you spot an error.

How much does Mochi Health cost per month?

Mochi Health charges $79/month for membership (covering video visits and dietitian access) plus $99/month for compounded semaglutide — a flat rate at all doses — for a total of approximately $178/month. Compounded tirzepatide adds up to $278/month total.

Total monthly cost for compounded semaglutide: ~$178/mo. For compounded tirzepatide: ~$278/mo. These are flat-rate figures — your cost doesn't increase as you titrate to higher doses, which is worth noting because some competitors charge more at higher dose levels.

The two-part pricing is worth understanding clearly: $79/mo is the membership that covers your clinical care and dietitian access, and the medication cost is separate. Some patients find this structure less intuitive than an all-in price. But the flat-rate medication model means no cost surprises as your dose increases.

HSA and FSA accounts are accepted for both the membership and medication costs.

What makes Mochi Health different?

Are the consultations with actual specialists?

Yes — Mochi's providers are board-certified in obesity medicine, and consultations happen via live video rather than asynchronous chat. This matters for clinical decision-making. A synchronous video visit allows your provider to ask follow-up questions, assess how you're tolerating medication in real time, and make nuanced titration decisions that async platforms can't match.

This is not a small distinction. The difference between a 15-minute video consultation with an obesity medicine specialist and an async message reviewed by a general practitioner is the difference between personalized medicine and a prescription factory.

Does Mochi charge more at higher doses?

No. Mochi charges $99/mo for compounded semaglutide regardless of dose level — a flat-rate model that saves money during titration. Many compounded GLP-1 providers charge more as you titrate to higher doses — $149/mo at a starting dose can become $399/mo at maintenance. For patients who need higher doses to reach therapeutic effect, this pricing model can save hundreds of dollars over a treatment course.

Is a registered dietitian included?

Yes. Registered dietitian consultations are included in the $79/mo membership. Most competitors at Mochi's price point don't offer dietitian access at all, and those that do (like Calibrate) charge significantly more. A registered dietitian can help with protein targets to mitigate lean muscle loss, meal planning around GLP-1 side effects like nausea, and long-term nutritional sustainability.

What medications does Mochi Health offer?

GLP-1 Medications

• Compounded semaglutide — $99/mo flat rate, all doses
• Compounded tirzepatide — $199/mo flat rate, all doses
• Brand Wegovy (semaglutide) — Available via insurance with prior authorization support
• Brand Zepbound (tirzepatide) — Available via insurance with prior authorization support

Non-GLP-1 Alternatives

• Topiramate — An anticonvulsant with weight loss effects; may be appropriate for patients who can't take or don't respond to GLP-1s
• Bupropion — An antidepressant that can support modest weight loss; sometimes used in combination
• Metformin — Primarily a diabetes medication with mild weight loss effects; relevant for patients with insulin resistance
• Orlistat — A lipase inhibitor that reduces fat absorption; different mechanism entirely from GLP-1s

The availability of non-GLP-1 options signals clinical flexibility. Not every patient is a GLP-1 candidate, and a provider willing to prescribe alternatives when appropriate is a provider making individualized clinical decisions.

What about the Eli Lilly lawsuit?

In 2025, Eli Lilly filed a lawsuit against Mochi Health alleging deceptive marketing practices related to compounded tirzepatide. This generated significant headlines and understandable patient concern.

The outcome: a federal court dismissed the case. Mochi continued operating throughout the proceedings.

What this means for patients: the legal challenge is resolved, and Mochi was not found liable. That said, the lawsuit reflects the broader tension between brand pharmaceutical manufacturers and the compounded medication market — a tension that affects every compounded GLP-1 provider, not just Mochi. Patients should understand that the regulatory landscape around compounded GLP-1 medications continues to evolve, and availability could change based on future FDA decisions regarding drug shortage designations.

What are the pros of Mochi Health?

• Obesity medicine specialists on video — Meaningfully more clinical depth than async-only providers
• Flat-rate medication pricing — $99/mo semaglutide at all doses eliminates cost surprises during titration
• Registered dietitian included — Rare at this price point; supports nutrition-focused care
• Non-GLP-1 options available — Clinical flexibility for patients who aren't GLP-1 candidates
• Insurance support for brand medications — Prior authorization handling included
• HSA/FSA accepted — Reduces effective cost for patients with pre-tax health accounts
• Available in 49 states — Broad geographic coverage

What are the cons of Mochi Health?

• Two-part pricing feels opaque — $79 membership + medication cost is less intuitive than all-in pricing from Ro ($149/mo) or Henry Meds ($149/mo)
• Lab work not included — Recommended but at additional cost; Calibrate includes comprehensive metabolic panels
• No structured coaching program — Dietitian access is valuable, but there's no equivalent to Calibrate's four-pillar metabolic reset or Found's health coaching
• Shipping delays reported — Some patients report inconsistent medication delivery timelines
• Customer service variability — Patient feedback suggests response times can be slow during peak periods
• Not available in Alabama — The sole state exclusion

Who is Mochi Health best for?

• Patients who want real clinical consultations — not just async prescription refills — but don't want to pay Calibrate's $299/mo program fee
• Those on higher GLP-1 doses who benefit from flat-rate pricing that doesn't penalize titration
• Patients who value dietitian guidance as part of their treatment, included at no extra cost
• People exploring non-GLP-1 options who want a provider with clinical flexibility
• Those with insurance who want help navigating prior authorizations for brand-name medications

Who should look elsewhere?

• Budget-focused patients — Ro ($149/mo all-in) and Henry Meds ($149/mo) are simpler and cheaper for compounded semaglutide
• Patients who want all-in transparent pricing without parsing membership fees and medication costs separately
• Those who need comprehensive metabolic monitoring — Calibrate's included lab panels are a better fit
• Patients who want structured coaching and behavior change programs — Calibrate or Found offer more on this front
• Anyone who prioritizes fast, reliable shipping and responsive customer support as non-negotiables

Is Mochi Health worth it?

Mochi Health delivers where it matters most: clinical quality. Board-certified obesity medicine specialists conducting real video consultations, registered dietitian access included in membership, and a thoughtful flat-rate dosing model that keeps costs predictable as you titrate up. Dr. Ahmad's background in obesity medicine is evident in how the platform is structured — this is a clinician-founded company, and it shows.

The weak spots are administrative, not clinical. The two-part pricing structure requires patients to do math that competitors handle for them. Shipping and customer service inconsistencies, while not universal, appear frequently enough in patient feedback to warrant mention. And the absence of included lab work means patients bear the cost and coordination of metabolic monitoring that ideally should accompany GLP-1 treatment.

At ~$178/mo for compounded semaglutide with specialist video visits and dietitian access, Mochi occupies a compelling price-to-clinical-quality position. It's the best online GLP-1 program for patients who want more than a prescription but aren't ready for Calibrate's full metabolic program. For anyone asking whether Mochi Health is worth it: if you'll actually use the video visits and dietitian, the answer is yes.

Rating: 4.0/5

Frequently Asked Questions

Is Mochi Health legit? Yes. Mochi Health was founded by Dr. Myra Ahmad, a UCSF-trained obesity medicine physician. The platform uses board-certified obesity medicine specialists and registered dietitians. A 2025 Eli Lilly lawsuit against Mochi was dismissed by a federal court — Mochi was not found liable.

How much does Mochi Health cost per month? Approximately $178/month for compounded semaglutide ($79 membership + $99 medication) or $278/month for compounded tirzepatide. Medication pricing is flat-rate at all dose levels. Brand-name GLP-1s are available through insurance.

Does Mochi Health take insurance? Mochi accepts insurance for brand-name GLP-1 medications (Wegovy, Zepbound) and handles prior authorization. The compounded medication programs are cash-pay only. HSA/FSA cards are accepted.

How do I cancel Mochi Health? Contact Mochi's support team to cancel. Some patients report delays in support response during peak periods — follow up in writing if needed.

Is Mochi Health's semaglutide FDA-approved? Mochi's compounded semaglutide is not FDA-approved as a finished product. Brand-name Wegovy and Zepbound (available through insurance) are FDA-approved. Compounded formulations carry regulatory risk as FDA enforcement of the GLP-1 compounding market continues.

How does Mochi compare to Ro for GLP-1? Ro charges $149/month all-in for compounded semaglutide with async-only care. Mochi charges ~$178/month but includes live video consultations with obesity medicine specialists and registered dietitian access. The $29/month difference buys significantly more clinical depth.

Data Sources & Methodology

Pricing and protocol data sourced from Mochi Health's public website and verified via checkout flow, April 2026. Patient experience data drawn from public reviews (Google, Trustpilot, Reddit) and independent patient outreach. Telehealth Ally has no commercial relationship with this provider. Rankings and ratings are editorial-only.

Related Resources

• Mochi Health Provider Profile — Medications, pricing, and consultation details
• Mochi Health vs. Found: Head-to-Head Comparison — Side-by-side breakdown of both programs
• Best GLP-1 Weight Loss Programs 2026 — All major providers ranked
• GLP-1 Prior Authorization Guide — Getting insurance to cover your treatment
• GLP-1 Cost & Insurance FAQ — What you'll actually pay